25 PATHOPHYSIOLOGY OF INCREASED ISCHAEMIC STROKE RISK IN AF FUNDING This study did not receive funding. GJG is supported by a VENI and VIDI grant from the Netherlands Organisation for Health Research and Development (ZonMw numbers 016.166.030 and 016.196.304). POTENTIAL CONFLICTS OF INTEREST FR and GJG report unrestricted institutional grants for performing research in the field of atrial fibrillation from Boehringer Ingelheim, Bayer Healthcare, Bristol-Myers Squibb/Pfizer Alliance and Daiichi Sankyo. The other authors declare that they have no conflicts of interest. CONTRIBUTORS All authors conceived and initiated the study. LJ and SvD wrote the first version of the manuscript. All authors critically reviewed and revised the manuscript. ACKNOWLEDGEMENT We express our gratitude to Prof. dr. H.J.G.M. Crijns (cardiologist) for his valuable input in earlier drafts of this paper. 2
RkJQdWJsaXNoZXIy MTk4NDMw